Pfizer Teams Up With University
Pfizer has agreed to pay $22.5 million over five years to researchers at Washington University's medical school as it tries to breathe new life into existing compounds developed for other uses. online.wsj.com |
ERT to Present at The BMO Capital Markets 10th Annual Focus on Healthcare Conference on August 5, 2010 (PR Newswire)
ERT , announced today that Dr. Michael J. McKelvey, the Company's President and CEO, and Keith Schneck, the Company's Executive Vice President and CFO, are scheduled to present at The BMO Capital Markets 10th Annual Focus on Healthcare Conference at 3:00 PM ET on August 5, 2010 in New York. us.rd.yahoo.com |
GE, Intel Form Health Joint Venture
General Electric and Intel announced plans to create a health-care joint venture focused on chronic disease and age-related conditions. online.wsj.com |
Novartis Beats Merck in Race for Approval of First Oral MS Pill
The Burrill Report submits: By Michael FitzhughGilenya has become the first oral multiple sclerosis pill capable of slowing the disease's progression and reducing relapses to win approval from the U.S. Food and Drug Administration. Novartis (NVS), developer of the drug, beat Merck's (MKGAY.PK) late-stage oral treatment cladribine to U.S. approval and could generate $1 billion in annual sales or more, according to both industry analysts and Novartis. Complete Story » seekingalpha.com |
U.S. Sues Michigan Blue Cross
The Justice Department filed an antitrust lawsuit Monday against Blue Cross Blue Shield of Michigan, alleging that provisions of the insurer's agreements with hospitals are anticompetitive. online.wsj.com |